|Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit|
|By: PR Newswire Association LLC. - 05 Aug 2022||Back to overview list
CHELMSFORD, Mass., Aug. 5, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-ubs-genomics-2-0-and-medtech-innovations-summit-301601020.html
SOURCE Azenta, Inc.
Copyright 2022 PR Newswire Association LLC.
|Back to overview list|